STOCK TITAN
  1. Home
  2. Sec-filings
  3. KPTI
  4. [SCHEDULE 13G] Karyopharm Therapeutics Inc. SEC Filing

[SCHEDULE 13G] Karyopharm Therapeutics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock KPTI logo
Karyopharm Therapeutics Inc

NASDAQ:KPTI

KPTI Rankings

#5182 Ranked by Market Cap
N/A Ranked by Dividends

KPTI Latest News

Sep 2, 2025
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 11, 2025
Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress
Aug 5, 2025
Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025
Aug 1, 2025
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 1, 2025
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KPTI Latest SEC Filings

Sep 4, 2025
[Form 4] Karyopharm Therapeutics Inc. Insider Trading Activity
Aug 11, 2025
[S-8] Karyopharm Therapeutics Inc. Employee Benefit Plan Registration
Aug 11, 2025
[10-Q] Karyopharm Therapeutics Inc. Quarterly Earnings Report
Aug 11, 2025
[8-K] Karyopharm Therapeutics Inc. Reports Material Event
Jul 30, 2025
[Form 4] Karyopharm Therapeutics Inc. Insider Trading Activity

KPTI Stock Data

58.40M
8.12M
6.29%
51.18%
24.62%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEWTON